Cargando…
Dual‐Antiplatelet Therapy After Percutaneous Coronary Intervention: How Short Is Too Short?
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939072/ https://www.ncbi.nlm.nih.gov/pubmed/36645091 http://dx.doi.org/10.1161/JAHA.122.028775 |
_version_ | 1784890764064456704 |
---|---|
author | Mourikis, Philipp Polzin, Amin |
author_facet | Mourikis, Philipp Polzin, Amin |
author_sort | Mourikis, Philipp |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9939072 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-99390722023-02-20 Dual‐Antiplatelet Therapy After Percutaneous Coronary Intervention: How Short Is Too Short? Mourikis, Philipp Polzin, Amin J Am Heart Assoc Original Research John Wiley and Sons Inc. 2023-01-16 /pmc/articles/PMC9939072/ /pubmed/36645091 http://dx.doi.org/10.1161/JAHA.122.028775 Text en © 2023 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Research Mourikis, Philipp Polzin, Amin Dual‐Antiplatelet Therapy After Percutaneous Coronary Intervention: How Short Is Too Short? |
title | Dual‐Antiplatelet Therapy After Percutaneous Coronary Intervention: How Short Is Too Short? |
title_full | Dual‐Antiplatelet Therapy After Percutaneous Coronary Intervention: How Short Is Too Short? |
title_fullStr | Dual‐Antiplatelet Therapy After Percutaneous Coronary Intervention: How Short Is Too Short? |
title_full_unstemmed | Dual‐Antiplatelet Therapy After Percutaneous Coronary Intervention: How Short Is Too Short? |
title_short | Dual‐Antiplatelet Therapy After Percutaneous Coronary Intervention: How Short Is Too Short? |
title_sort | dual‐antiplatelet therapy after percutaneous coronary intervention: how short is too short? |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939072/ https://www.ncbi.nlm.nih.gov/pubmed/36645091 http://dx.doi.org/10.1161/JAHA.122.028775 |
work_keys_str_mv | AT mourikisphilipp dualantiplatelettherapyafterpercutaneouscoronaryinterventionhowshortistooshort AT polzinamin dualantiplatelettherapyafterpercutaneouscoronaryinterventionhowshortistooshort |